8.55; Cl, 13.36. C23H44O8Cl2 requires C, 53.18; H, 8.47; Cl,
13.48%).
(100) (Found: C, 65.00; H, 9.28; N, 2.52. C30H51NO8 requires C,
65.09; H, 9.22; N, 2.53%).
Methyl 4,6-di-O-butyl-2,3-bis-O-[2-(2-iodoethoxy)ethyl]-ꢀ-D-
glucopyranoside 7
N-(2-Phenylethyl)-2,3,5,6,8,9,11,12,14,15-decahydro(methyl
4,6-di-O-butyl-2,3-dideoxy-ꢀ-D-glucopyranosido)[2,3-e]-1,4,7,
10-tetraoxa-13-azacyclopentadecine 11. Column chromato-
graphy afforded syrupy 11 (1.2 g, 45%), [α]D ϩ51.3 (c 1, CHCl3);
νmax (neat film)/cmϪ1 2932, 2862 (Me, methylene), 1462, 1360
(alkyl chain), 1120, 1097, 1056 (C–O), 1600, 738, 700 (Ar); δH
(CDCl3) 0.84–0.97 (6H, m, CH3), 1.32–1.44 (6H, m, CH2),
1.52–1.66 (6H, m, CH2), 2.62–2.91 (8H, m, NCH2 and CH2Ph),
3.38 (3H, s, OCH3), 3.44–3.92 (18H, m, CH and CH2 groups),
4.82 (1H, d, J 4.8, anomer-H), 7.15–7.32 (5H, m, ArH); EI-MS
m/z 567 (Mϩ, 13%), 536 (Mϩ Ϫ OCH3, 54), 476 (Mϩ Ϫ CH2Ph,
95), 105 (100) (Found: C, 65.38; H, 9.36; N, 2.42. C31H53NO8
requires C, 65.60; H, 9.34; N, 2.47%).
A mixture of bischloro derivative 6 (6.0 g, 11.55 mmol) and
anhydrous NaI (6.9 g, 47.1 mmol) in dry acetone (150 cm3) was
stirred under reflux for 40 h. After cooling, the precipitate was
filtered off and washed with acetone. The combined acetone
solution was evaporated. The residue was dissolved in dichloro-
methane (100 cm3), and the solution was washed with water
(3 × 50 cm3) and dried (Na2SO4) to give compound 7 (7.8 g,
96%) as a syrup, [α]D ϩ46.3 (c 1, CHCl3); νmax(neat film)/cmϪ1
2957, 2871 (Me, methylene), 1726 (sugar ring), 1105, 1052
(C–O), 1460, 1357 (alkyl chain), 545 (C–I); δH (CDCl3) 0.85–
0.96 (6H, m, CH3), 1.32–1.40 (6H, m, CH2), 1.52–1.64 (6H, m,
CH2), 3.27 (4H, t, CH2I), 3.38 (3H, s, OCH3), 3.45–4.10 (18H,
m, CH and CH2 groups), 4.82 (1H, d, J 4.8, anomer-H).
N-Tosyl-2,3,5,6,8,9,11,12,14,15-decahydro(methyl 4,6-di-O-
butyl-2,3-dideoxy-ꢀ-D-glucopyranosido)[2,3-e]-1,4,7,10-tetra-
oxa-13-azacyclopentadecine 12
General method for preparation of crown ethers 8–11
A mixture of bischloro podand 6 (2.6 g, 5.0 mmol),
toluene-p-sulfonamide (0.86 g, 5.0 mmol) and anhydrous
K2CO3 (3.5 g, 25.3 mmol) was stirred and refluxed in dry DMF
(150 cm3) for 32 h. After the reaction was complete, the precipi-
tate was filtered off and washed with chloroform. The com-
bined filtrate and washings were evaporated under reduced
pressure, and the residue was dissolved in chloroform, washed
with water, and dried (MgSO4). After removal of the solvent,
column chromatography of the residue on silica gel with
toluene–methanol (10:1) as the eluent gave the N-tosyl macro-
cycle 12 as a yellow oil (1.6 g, 52%), [α]D ϩ33.4 (c 1.8, CHCl3);
δH (CDCl3) 0.80–0.96 (6H, m, CH3), 1.32–1.42 (6H, m, CH2),
1.52–1.66 (6H, m, CH2), 2.41 (3H, s, ArCH3), 2.72–2.98 (4H, m,
NCH2), 3.40 (3H, s, OCH3), 3.45–3.90 (18H, m, CH and CH2
groups), 4.88 (1H, d, J 4.8, anomer-H), 7.22–7.70 (4H, m,
ArH); MS (FAB) m/z 618 (MHϩ) (Found: C, 58.44; H, 8.28;
N, 2.21. C30H51NO10S requires C, 58.34; H, 8.26; N, 2.26%).
Anhydrous Na2CO3 (3.8 g, 36.2 mmol) was suspended in a solu-
tion of the corresponding primary amine (4.60 mmol) and the
bisiodo compound 7 (3.45 g, 4.60 mmol) in dry acetonitrile (100
cm3) under argon. The stirred reaction mixture was refluxed for
32–40 h and monitored by TLC. After cooling, the precipitate
was filtered off and washed with acetonitrile. The combined
acetonitrile solution was concentrated; the residual oil was dis-
solved in chloroform, amd the solution was washed with water,
dried (Na2SO4), and concentrated. The residue was purified
by column chromatography on silica gel with chloroform–
methanol (10:0.5–10:2) to afford the title compounds.
N-Butyl-2,3,5,6,8,9,11,12,14,15-decahydro(methyl 4,6-di-O-
butyl-2,3-dideoxy-ꢀ-D-glucopyranosido)[2,3-e]-1,4,7,10-tetra-
oxa-13-azacyclopentadecine 8. Column chromatography gave
syrupy 8 (1.1 g, 46%), [α]D ϩ57.4 (c 1, CHCl3); νmax(neat film)/
cmϪ1 2930, 2862 (Me, methylene), 1462, 1359 (alkyl chain),
1120, 1097, 1056 (C–O); δH (CDCl3) 0.84–0.96 (9H, m, CH3),
1.22–1.78 (16H, m, CH2), 2.47–2.88 (6H, m, NCH2), 3.38 (3H,
s, OCH3), 3.43–3.83 (18H, m, CH and CH2 groups), 4.82 (1H,
d, J 4.8, anomer-H); EI-MS; m/z 519 (Mϩ, 17%), 488
(Mϩ Ϫ OCH3, 67), 476 (Mϩ Ϫ C3H7, 91), 105 (100) (Found: C,
62.29; H, 10.12. C27H53NO8 requires C, 62.42; H, 10.21%).
2,3,5,6,8,9,11,12,14,15-Decahydro(methyl 4,6-di-O-butyl-2,3-
dideoxy-ꢀ-D-glucopyranosido)[2,3-e]-1,4,7,10-tetraoxa-13-aza-
cyclopentadecine 13
Compound 12 (1.4 g, 2.27 mmol), anhydrous disodium hydro-
gen phosphate (1.3 g, 9.10 mmol), and 4% sodium amalgam
(11.0 g, 19.1 mmol) were placed in dry methanol (20 cm3). The
mixture was heated at reflux under a nitrogen atmosphere for
20 h while being stirred rapidly. After cooling to room temper-
ature, the resulting slurry was decanted into water (80 cm3) and
extracted with chloroform (30 cm3 × 4). The organic layers were
combined, dried (MgSO4), and evaporated under reduced pres-
sure to yield compound 13 (0.89 g, 85%) as a yellow oil, [α]D
ϩ58.9 (c 1.5, CHCl3); δH (CDCl3) 0.84–0.96 (6H, m, CH3),
1.32–1.42 (6H, m, CH2), 1.52–1.66 (6H, m, CH2), 2.45 (1H, br s,
NH), 2.82–2.98 (4H, m, NCH2), 3.40 (3H, s, OCH3), 3.44–3.92
(18H, m, CH and CH2 groups), 4.83 (1H, d, J 4.8, anomer-H);
MS (FAB) m/z 464 (MHϩ) (Found: C, 59.50; H, 9.68; N, 3.08.
C23H45NO8 requires C, 59.61; H, 9.72; N, 3.02%).
N-(3-Methoxypropyl)-2,3,5,6,8,9,11,12,14,15-decahydro-
(methyl 4,6-di-O-butyl-2,3-dideoxy-ꢀ-D-glucopyranosido)[2,3-e]-
1,4,7,10-tetraoxa-13-azacyclopentadecine 9. Compound 9 (0.84
g, 42%) was obtained as a syrup after chromatography, [α]D
ϩ55.1 (c 1, CHCl3); νmax (neat film)/cmϪ1 2930, 2862 (Me,
methylene), 1462, 1360 (alkyl chain), 1120, 1100, 1056 (C–O);
δH (CDCl3) 0.84–0.96 (6H, m, CH3), 1.32–1.42 (6H, m, CH2),
1.52–1.66 (6H, m, CH2), 2.47–2.88 (6H, m, NCH2), 3.32 (3H, s,
OCH3), 3.39 (3H, s, OCH3), 3.45–3.92 (22H, m, CH and CH2
groups), 4.82 (1H, d, J 4.8, anomer-H); EI-MS m/z 535 (Mϩ,
8%), 504 (Mϩ Ϫ OCH3, 58), 476 (Mϩ Ϫ CH2CH2OCH3, 89),
105 (100) (Found: C, 60.48; H, 9.94; N, 2.58. C27H53NO9
requires C, 60.56; H, 9.90; N, 2.61%).
General procedure for the Michael addition
N-Benzyl-2,3,5,6,8,9,11,12,14,15-decahydro(methyl 4,6-di-O-
butyl-2,3-dideoxy-ꢀ-D-glucopyranosido)[2,3-e]-1,4,7,10-tetra-
oxa-13-azacyclopentadecine 10. Column chromatography
afforded syrupy 10 (1.0 g, 40%); [α]D ϩ56.2 (c 1.2, CHCl3); νmax
(neat film)/cmϪ1 2932, 2862 (Me, methylene), 1462, 1360 (alkyl
chain), 1120, 1097, 1056 (C–O), 1600, 738, 700 (Ar); δH (CDCl3)
0.84–0.97 (6H, m, CH3), 1.32–1.44 (6H, m, CH2), 1.52–1.66
(6H, m, CH2), 2.62–2.90 (6H, m, NCH2 and CH2Ph), 3.38 (3H,
s, OCH3), 3.44–3.92 (18H, m, CH and CH2 groups), 4.82 (1H,
d, J 4.8, anomer-H), 7.15–7.32 (5H, m, ArH); EI-MS m/z 553
(Mϩ, 13%), 536 (Mϩ Ϫ OCH3, 54), 476 (Mϩ Ϫ CH2Ph, 95), 105
This was performed as follows: Chalcone 14 (0.3 g, 1.44 mmol)
and 2-nitropropane 15 (0.3 cm3, 3.36 mmol) were dissolved in
dry toluene (3 cm3), and crown ether catalyst (0.1 mmol) and
sodium tert-butoxide (0.05 g, 0.5 mmol) were added. The mix-
ture was stirred under an argon atmosphere at room temper-
ature. After completion of the reaction (20–24 h) a mixture of
toluene (7 cm3) and water (10 cm3) was added. The organic
phase was processed in the usual manner. The product was
purified by preparative TLC on silica gel using hexane–ethyl
acetate (10:1) as eluent, and had mp 146–148 ЊC, [α]D ϩ80.8
3654
J. Chem. Soc., Perkin Trans. 1, 1999, 3651–3655